The impact of COVID-19 vaccination on the risk of hospitalization in Fayoum healthcare workers

Shaimaa Abdallah Gebili; Amal Ali Abu El Hassab; Ashraf Ibrahim Mohammed; Asmaa Rohym; Hatem Gamal El-Din; Mohamed Abdelhamed Fathy; Ahmed Mohamed Ahmed Abdelhafez; Asmaa Younis Elsary

doi:10.18203/2394-6040.ijcmph20240872

Authors

Shaimaa Abdallah Gebili Fayoum Clinical Research Unit, Fayoum Directorate of Health Affairs, The Ministry of Health and Population, Egypt
Amal Ali Abu El Hassab Fayoum Directorate of Health Affairs, Health IT Manager Fayoum Fever Hospital, Egypt
Ashraf Ibrahim Mohammed Fayoum Directorate of Health Affairs, Surveillance Coordinator Fayoum Fever Hospital, Egypt
Asmaa Rohym Fayoum Directorate of Health Affairs, The Ministry of Health and Population, Egypt
Hatem Gamal El-Din Fayoum Directorate of Health Affairs, The Ministry of Health and Population, Egypt
Mohamed Abdelhamed Fathy Technical Office, The Ministry of Health and Population, Egypt
Ahmed Mohamed Ahmed Abdelhafez Fayoum Health Council, Fayoum Directorate of Health Affairs, The Ministry of Health and Population, Egypt
Asmaa Younis Elsary Public Health and Community Medicine, Faculty of Medicine, Fayoum University, Egypt

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20240872

Keywords:

Vaccination, COVID-19, HCWs, Hospitalization, Egypt

Abstract

Background: Healthcare workers (HCWs) face several challenges including treating COVID-19 patients. The immunization of the population through vaccination is recognized as a public health priority. The aim of the study is to assess the impact of vaccination on the risk of hospitalization and mortality in HCWs due to COVID-19 infection.

Methods: This study was conducted in Egypt in El Fayoum governorate on the HCWs from April 2021 to the end of the year 2021. A cohort retrospective approach was carried out using (the national electronic disease surveillance system) NEDSS and COVID-19 vaccine registration system. Hospitalization is determined by assessment of the cases according to the protocol of COVID-19 management of MOHP November 2020.

Results: There was no association between hospitalization and both sex and residence (p=0.1, and 0.06 respectively). There was no statistical significant association between hospitalization and vaccination (time, status, or type). The p=0.2, 0.6, and 0.07 respectively. Age and the presence of comorbidities were statistically significant predictors with p=0.004 and 0.04, respectively, as increasing age and the presence of comorbidities will increase the likelihood of hospitalization by 1.04 and 1.9 folds, respectively.

Conclusions: This study shows no significant association between vaccination and hospitalization of HCWs.

Metrics

Metrics Loading ...

References

Coronavirus Disease 2019 (COVID-19). CDC. Available at: https://www.cdc.gov/coronavirus/2019-ncov/index.html. Accessed on 12 January, 2024.

Shrestha UK. Adaptive immunity against COVID-19. J Adv Internal Med. 2020;9(2):44-6.

Coronavirus Disease 2019 (COVID-19): Practice Essentials, Background, Route of Transmission. Available at: https://emedicine.medscape.com/article/ 2500114-overview. Accessed on 12 January, 2024.

Mitigating the COVID-19 outbreak through global data sharing. Available at: https://www.who. int/teams/health-care-readiness/COVID-19/data-platform/mitigating-the-covid-19-outbreak-through-global-data-sharing. Accessed on 12 January, 2024.

Cai Q, Feng H, Huang J, Wang M, Wang Q, Lu X, et al. The mental health of frontline and non-frontline medical workers during the coronavirus disease 2019 (COVID-19) outbreak in China: A case-control study. J Affect Disord. 2020;275:210–5.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395(10223):497-506.

Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418-23.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 2020;323(11):1061-9.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China Medical Treatment Expert Group for COVID-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Eng J Med. 2020;382(18):1708-20.

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42.

Lopes-Pacheco M, Silva PL, Cruz FF, Battaglini D, Robba C, Pelosi P, et al. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies. Frontiers Physiol. 2021;12:593223.

COVID-Coronavirus Statistics-Worldometer. 2023. Available at: https://www.worldometers.info/ coronavirus/. Accessed on 12 January, 2024.

Buchegger S. Analyzing the economic burden of COVID-19 patient hospitalization and testing: A comparison between the Netherlands and Germany. J Heal Social Studies. 2020;9(57):e67-78.

Ferland L, Carvalho C, Gomes Dias J, Lamb F, Adlhoch C, Suetens C, et al. Risk of hospitalization and death for healthcare workers with COVID-19 in nine European countries. J Hospital Infection. 2022;119:170-74.

An X, Xiao L, Yang X, Tang X, Lai F, Liang XH. Economic burden of public health care and hospitalisation associated with COVID-19 in China. Public Health. 2022;203:65-74.

Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nature Rev Immunol. 2020;20(10):615-32.

Calina D, Docea AO, Petrakis D, Egorov AM, Ishmukhametov AA, Gabibov AG, et al. Towards effective COVID 19 vaccines: Updates, perspectives and challenges (Review). Int J Mol Med. 2020;46(1):3-16.

Juul S, Nielsen EE, Feinberg J, Siddiqui F, Jørgensen CK, Barot E, et al. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). PLoS Med. 2020;17(9):e1003293.

Biswas N, Mustapha T, Khubchandani J, Price JH. The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers. J Community Heal. 2021;46(6):1244-51.

Abdullahi LH, Kagina BM, Ndze VN, Hussey GD, Wiysonge CS. Improving vaccination uptake among adolescents. Cochrane Database Systematic Rev. 2020;1(1):CD011895.

Girgis N, Elnahry W, Afifi S, El Shourbagy S, Abu Elsood H, Eid A. Evaluation of the National Electronic Disease Surveillance System Amid the COVID-19 Pandemic in Elsahel District, Cairo Governorate, Egypt. 2020 Proc. 2022;8(1):e36514.

Management Protocol for COVID-19 Patients MoHP Protocol for COVID19. 2020. Available at: https://micrositesstorge.blob.core.windows.net/product/Guideline_39. Accessed on 12 January, 2024.

Dhar J, Samanta J, Kochhar R. Corona Virus Disease-19 pandemic: The gastroenterologists' perspective. Indian J Gastroenterol. 2020;39(3):220-31.

WHO announces COVID-19 outbreak a pandemic. Available at: https://reliefweb.int/report/world/who-announces-covid-19-outbreak-pandemic?gclid= EAIaIQobChMI-MK95bbx_AIVhYXVCh1JtweKE AAYAiAAEgL0wvD_BwE. Accessed on 12 January, 2024.

Reddy V, Sharma D. COVID 19 in neonates. J Maternal Fetal Neonatal Med. 2022;35:8:1610-18.

Egypt: WHO Coronavirus Disease (COVID-19) Dashboard with Vaccination Data | WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Available at: https://covid19. who.int/region/emro/country/eg. Accessed on 12 January, 2024.

Chilamakuri R, Agarwal S. COVID-19: Characteristics and Therapeutics. Cells. 2021;10(2):206.

WHO. Coronavirus disease (COVID-19). Available at: https://www.who.int/health-topics/coronavirus# tab=tab_2. Accessed on 12 January, 2024.

WHO. COVID-19 vaccines: everything you need to know. Available at: https://www.who.int/news-room/feature-stories/detail/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-. Accessed on 12 January, 2024.

WHO. The Sinovac-CoronaVac COVID-19 vaccine: What you need to know. 2022. Available at: https://www.who.int/news-room/feature-stories/ detail/the-sinovac-covid-19-vaccine-what-you-need-to-know?gclid=Cj0KCQjwnf-kBhCnARIsAFlg491 XtKnMZPK8D-6YDAWotKiiwQUrbCOeIei HmL8mFSjATJNa2RxexYQaAn7-EALw_wcB. Accessed on 12 January, 2024.

WHO. The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need to know. 2022. Available at: https://www.who.int/news-room/feature-stories/ detail/who-can-take-the-pfizer-biontech-covid-19--vaccine-what-you-need-to-know. Accessed on 12 January, 2024.

WHO. The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know. 2022. Available at: https://www.who.int/news-room/feature-stories/ detail/the-moderna-covid-19-mrna-1273-vaccine-what-you-need-to-know?gclid=EAIaIQobChMIhM-hNCr_QIV-I9oCR3PjQHjEAAYASAAEgLVD_D_ BwE. Accessed on 12 January, 2024.

Morón-Duarte LS, Chacón KR, Gutiérrez MP, De La Hoz IH, Yomayusa N. Efficacy and safety of four COVID-19 vaccines in preventing SARS-CoV-2 infection: A rapid review. Eficacia y seguridad de cuatro COVID-19 vacunasparaprevenir la infecciónpor SARS-CoV-2: unarevisión-rápida. Biomedica: Revista del Instituto Nacional de Salud. 2022;42(2):19-31.

Vaccines work. Everything we know about Johnson and Johnson’s single-dose COVID-19 vaccine (Feb.2021). Available at: https://www.gavi.org/ vaccineswork/everything-we-know-about-johnson-johnsons-single-dose-covid-19-vaccine?gclid= EAIaIQobChMIic6notOr_QIVloXVCh1VGwXaEAAYASAAEgI8t_D_BwE. Accessed on 12 January, 2024.